Article
Intranasal self-amplifying RNA SARS-CoV-2 vaccine produces protective respiratory and…
medRxiv · 2024 · Jennewein, M. F.; Schultz, M. D.; Beaver, S.; Battisti, P.; Bakken, J.; Hanson, D.; Akther, J.; Mohamath, R.; Singh, J.; Cross, N.; Reed, S.; Kalange, D.; Foote, J. B.; King, R. G.; Silva-Sanchez, A.; Botta, D.; Gerhardt, A.; Casper, C.; Randall, T. D.; Lund, F. E.; Voigt, E. A.
Key facts
| Title | Intranasal self-amplifying RNA SARS-CoV-2 vaccine produces protective respiratory and systemic immunity and prevents viral transmission |
|---|---|
| First author | Jennewein, M. F.; Schultz, M. D.; Beaver, S.; Battisti, P.; Bakken, J.; Hanson, D.; Akther, J.; Mohamath, R.; Singh, J.; Cross, N.; Reed, S.; Kalange, D.; Foote, J. B.; King, R. G.; Silva-Sanchez, A.; Botta, D.; Gerhardt, A.; Casper, C.; Randall, T. D.; Lund, F. E.; Voigt, E. A. |
| Journal | medRxiv |
| Published | Jan 1, 2024 |
| DOI | 10.1101/2022.11.10.515993 |
| Devices mentioned | K800781, K822496 |
| Product codes mentioned | JCJ, MVU, JIT, KIS |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1